



Early Detection and Intervention of ASD:
A European Overview
María Magán-Maganto 1 ID , Álvaro Bejarano-Martín 1,* ID , Clara Fernández-Alvarez 1 ID ,
Antonio Narzisi 2, Patricia García-Primo 3, Rafal Kawa 4, Manuel Posada 3 ID and
Ricardo Canal-Bedia 1 ID
1 INICO, Instituto Universitario de Integración en la Comunidad, Universidad de Salamanca,
37005 Salamanca, Spain; mmmaria@usal.es (M.M.-M.); cjf2146@columbia.edu (C.F.-A);
rcanal@usal.es (R.C.-B.)
2 IRCCS Stella Maris Foundation, 56018 Pisa, Italy; antonio.narzisi@fsm.unipi.it
3 IIER, Instituto de Salud Carlos III, 28029 Madrid, Spain; PGARCIAPRIMO@externos.isciii.es (P.G.-P.);
mposada@isciii.es (M.P.)
4 Faculty of Psychology, University of Warsaw, Stawki 5/7, 00-183 Warszawa, Poland;
rkawa@psych.uw.edu.pl
* Correspondence: alvaro_beja@usal.es; Tel.: +34-923-294-400 (ext. 3342)
Received: 17 October 2017; Accepted: 28 November 2017; Published: 1 December 2017
Abstract: Over the last several years there has been an increasing focus on early detection of Autism
Spectrum Disorder (ASD), not only from the scientific field but also from professional associations
and public health systems all across Europe. Not surprisingly, in order to offer better services and
quality of life for both children with ASD and their families, different screening procedures and
tools have been developed for early assessment and intervention. However, current evidence is
needed for healthcare providers and policy makers to be able to implement specific measures and
increase autism awareness in European communities. The general aim of this review is to address
the latest and most relevant issues related to early detection and treatments. The specific objectives
are (1) analyse the impact, describing advantages and drawbacks, of screening procedures based
on standardized tests, surveillance programmes, or other observational measures; and (2) provide a
European framework of early intervention programmes and practices and what has been learnt from
implementing them in public or private settings. This analysis is then discussed and best practices are
suggested to help professionals, health systems and policy makers to improve their local procedures
or to develop new proposals for early detection and intervention programmes.
Keywords: ASD; screening tools; detection; early intervention; Europe
1. Introduction
Autistic Spectrum Disorders (ASD) are severe early-onset neurodevelopmental disorders
characterized by significant difficulties in social communication, as well as restrictive interests and
repetitive behaviours that critically affect daily living activities [1]. Over the last years there has
been a very significant increase in ASD prevalence. Several prevalence studies conducted in the
European context indicate rates reaching or exceeding 1% [2,3]. Other prevalence studies conducted in
non-European regions have higher prevalence estimates ranging from 1.47% [4] to 2.64% [5]. Indeed,
there is no doubt that the prevalence of ASD has steadily increased over the past 30 years [6]. Regardless
of the possible causes for such increase, one of the consequences acknowledged internationally is that
healthcare systems will have to be structured and organized accordingly, to address the needs of the
growing population of children diagnosed with ASD. Therefore, there is an imperative necessity to
know and reflect on current screening, diagnosis and treatment strategies, as a way to find effective
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solutions to guarantee that children with ASD and their families receive the required attention in order
to achieve optimal treatment results.
An important factor in this reflection is that both parents and relatives experience the emergence
of ASD symptoms in a child as a very worrying and usually destabilizing event of the personal and
family well-being. Consequently, from that moment on a generally complex and long process of
adaptation begins, in which they hastily have to face challenges such as receiving a formal diagnosis,
accessing an appropriate treatment and adapting the family’s (and professional) dynamics to this
new reality of autism in the family. Among the aspects that have been identified as contributors to
this loss of well-being (besides individual factors associated with the characteristics of the children
and their parents), there are contextual factors related to the social environment and availability of
professional support services. For instance, one of the main sources of parental stress reported by
parents of children with ASD is the lack of adequate professional support [7]. It has also been found
that the delay in attending to the parents’ initial concerns, the diagnostic delay and not accompanying
the diagnosis (even if it is early) with concrete guidelines for the intervention, increases the parents’
stress [8].
Despite the high and increasing prevalence of ASD and the personal and family costs of autism,
these disorders have received little attention in the European public health services field (and in the rest
of the world). The personal and family characteristics mentioned above have important implications in
terms of planning and prioritizing healthcare, educational and social services. In order to promote the
development of more appropriate strategies aimed at improving the response to autism, the European
Parliament adopted in 2015 the Written Declaration on Autism, calling for a European strategy for
autism that supports accurate detection and diagnosis across Europe and promote evidence-based
interventions for children with autism. The Directorate-General for Health and Food Safety (DG
Santé) of the European Commission agreed to fund Autism Spectrum Disorders in the European
Union (ASDEU) project [9] whose efforts, within Work Package 2, are specifically aimed at promoting
successful early detection and evidence-based early intervention for people with autism and their
families in the European context.
Thus, the general objective of this literary review is to describe the different screening procedures,
as well as early intervention programmes for ASD reported in scientific publications based on European
experiences, placing more emphasis on contextual factors. As a specific objective, a description of the
advantages and disadvantages of different screening experiences will be provided (both test-based
screening programmes as well as developmental surveillance programmes and other observational
measures for this purpose) with the ultimate purpose of examining their impact within the context in
which they are applied. In addition, this review will also give account of the different programmes
and practices of early intervention for ASD and will describe the different characteristics or knowledge
that has been obtained from applying them in public or private settings.
This paper is structured as follows: Sections 2 and 3 presents the screening programme topic and
Sections 4 and 5 the early intervention subject. A final Section 6 has been added to conclude with the
integration of information about both topics. Section 2 introduces the methodology followed to review
the screening programmes in the first paragraph and all the consequent text presents a narrative of
the results obtained, accompanied by Tables 1–3, where all the information has been synthetized.
In Section 3, the main strengths and limitations of the screening programmes have been discussed.
Section 4 introduces the main results on early intervention programmes and Section 5 focuses on
the analysis of European practices. The article concludes with a set of proposals for action aimed at
professionals and researchers.
2. Description of the Early Detection ASD Experiences in Europe
According to the research conducted under the ASDEU project [9] (see Table A1 in Appendix A
for the search strategy), in Europe there are 6 studies (see Figure 1 for the study selection process
and more details of the methodology protocol can be provided upon request) published in scientific
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English peer-review journals (to assure the replicability of the study) between January 1992 and April
2015, which describe in ample detail the scientific research on early screening for ASD and other
neurodevelopmental disorders, more specifically for the age range of 14–36 months and targeting
the general population (Level 1). These 6 detection references meet quality criteria, providing the
necessary data to evaluate the effectiveness of the screening programme of each study. Other studies
were excluded for the following reasons: (a) duplicate participant data in study sample; (b) did not
include diagnostic evaluations supported by the scientific community as a gold standard for the
confirmation of positive cases; or (c) did not include a summary of the diagnosis given to each case.
After concluding the search process, the ASDEU researchers’ network was contacted to inquire about
unpublished ongoing screening experiences or studies that were in the process of publication. As a
result, a study that met the criteria mentioned above, carried out in France and recently published [10],
was added to this review. In addition, another two on-going studies with unpublished data, one in
Italy (Q-CHAT [11]) and another one in Spain (M-CHAT-R [12]), are currently being carried out.
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Table 1 shows a summary of the ASD early detection tools most frequently used in the European
context and their most relevant characteristics. The Checklist for Autism in Toddlers (CHAT) [13,14]
was the first tool that was applied in Europe and the only one originally developed in our continent.
The work developed to create this tool has served as a conceptual and methodological basis for the
development of other instruments subsequently created, which in some cases have achieved more
satisfactory results when applied to the general population, such as Modified Checklist for Autism
in Toddlers (M-CHAT) [15], the Early Screening Autistic Traits Questionnaire (ESAT) [16,17] and the
Checklist for Early Signs of Developmental Disorders (CESDD) [18], with M-CHAT being one of the
most frequently used tools across published studies conducted in Europe.
Table 1. Screening tools characteristics used in European studies for early detection of ASD.
Screening Tools Developmental Areas Measured N Items
Application






interest and Social play.










mind; Early language and
communication











reaction and Social interaction
14 14–15 10
Rated by parents






Different target behaviours but no
specific developmental areas 25 + 4
2 3–36 - Rated by child careworkers
Joint Attention-
Observation
Schedule, [19] Joint-attention 5 20–48 5–10
Nurse observation
schedule
ASD: Autism Spectrum Disorders; Min: Minutes; 1 Nine items rated by parents and five observational rated by
health providers; 2 25 items related to ASD target behaviours and four items related to language.
Similar to CHAT, all of these instruments are based on a conceptual analysis of early
communication development and ‘red flags’ commonly described in scientific literature as early
ASD indicators, most of which stress difficulties in joint attention, social interaction, visual contact and
in playing skills as important ASD risk indicators. For instance, item 12 of the M-CHAT (Does your
child smile in response to your face or your smile?) and item 5 of the CESDD (The child seldom/never
smiles socially, etc.) collect information about difficulties in social interaction. Furthermore, item 5 of
the CHAT and M-CHAT, item 25 of the CESDD and the observation number 3 of the CHAT assess
difficulties in symbolic play. Even though the similarity in the content of the items’ and wording is
notable, it is important to promote empirical studies comparing the content of the items of the different
instruments, in such a manner as to analyse if they are measuring the same behaviours and also if the
discriminative and predictive validity of the items is similar in the different instruments. However,
this question is beyond the scope of this article.
There is a conceptual discrepancy between the different instruments and the CHAT, in that
the latter does not include items related to stereotyped behaviour, which are, however, included in
the other instruments. From a universal point of view, the instruments differ in terms of: number
of items; number of items devoted to identifying each one of the behavioural areas of difficulty;
the characteristics of the person to be informed and the type of data that must be recorded (direct
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observational data such as the Joint Attention-Observation Schedule (JA-OBS) and section B of the
CHAT, or responses from parents or professionals).
Screening programmes use different strategies to reduce false positive and negative cases to
increase the efficacy of the process. The purpose of reducing the number of false positive cases is
that it would increase the specificity of the programme and lower the overall cost of the programme.
Therefore, fewer resources would be necessary for conducting a smaller number of evaluations.
A strategy frequently used is to have different stages in the screening process; for instance, a verification
telephone interview is conducted for positive cases in the M-CHAT questionnaire. Another strategy
described in the studies analysed to minimize the number of false negatives and thereby increase the
sensitivity of the programme, is to combine different tools in the screening process. This is a common
practice across the different selected studies (see Table 2). Moreover, one could also opt to repeat the
screening at different ages as a follow-up. The latter strategy allows the programme to become a
development surveillance tool and screening assumes an evolutionary approach.
Regarding the context of these investigations, most of the studies described in this review have
implemented ASD screening programmes in collaboration with the public health system of the
countries where the studies were conducted, specifically in the primary care services and children
surveillance programmes. In these situations, with the research team and psychiatric units or other
specialized clinics work closely together to proceed with the diagnostic evaluations of the positive
cases, with the exception of the investigation of [18], in which day-care centres performed the initial
pre-screening (see Table 2).
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Table 2. European ASD screening studies characteristics.
Screening Studies &
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Another important aspect that should be highlighted regarding the ASD screening programmes
for the general population is the estimation of their scope; the number of the total population that
meets the characteristics required for the study sample and the contrast with the number of subjects
finally screened. That is to say, the objective is to detect the highest number of children within the
range of 14–36 months who could be given an ASD diagnosis. A population’s sample size is a difficult
number to record systematically and part of this difficulty is due to a combination of human factors
and the type of information resources used, such as birth records, global data from national statistical
services, cohort studies, patient records from clinical services, estimation of the disorder’s prevalence
obtained in other studies, proportionate sample collection, etc. Hence, this is a complicated number to
estimate and is not often available to research teams.
However, all the studies reviewed addressed this issue, some in a more specific manner, reporting
mostly about low participation rates (about 40%) and others describing only the scope of the total
population within the collaborating institutions with the screening, without providing the actual data
(see Table 2). This is the case of the study conducted in Spain, where the ASD screening programme is
based on the fact that public health services reach the entire population in Spain and have a medical
check-up system for healthy infants that is universal and free. This is the reason to point out that
primary care services are the appropriate context for a population early screening programme.
There is considerable variability in the estimated prevalence of ASD reported in the different
studies, values ranging from 5.67 [17] to 120.03 [19] ASD cases per 10,000 people (see Table 2).
These data should be interpreted with caution, as the values offered in the different studies depend
on the mean age during which the participants are detected and in many cases the information is not
comparable because the population is selected at different developmental stages, commonly detecting
fewer cases at earlier ages. For instance, the study carried out in the United Kingdom (UK) with
the CHAT [14] reported an estimated 6.2 ASD cases per 10,000 at 18 months; this number is close to
the 5.6 ASD cases per 10,000 estimated by the Netherlands study [17] which had a sample mean age
of 15-months. Yet, in the Belgian study [18] an estimated prevalence of 60.22 ASD cases per 10,000
was reported, as all cases referred for evaluation at the end of all screening stages were taken into
account. This last prevalence value is very close to the 57.9 ASD cases per 10,000 obtained in the UK
using the CHAT screening tool, study that followed a two-stage implementation strategy that lasted 6
years and combined up to 5 detection and surveillance methods during the duration of the study [14].
The study by Nygren and colleagues [19] procured even higher rates, reaching 80 cases per 10,000
using a two-stage strategy and both screening tools, the M-CHAT and the JA-OBS.
An explanation for the variability in ASD prevalence rates is that not all programmes use a strategy
to detect false negatives cases, owing to the great economic cost of classifying all participants correctly
within the programme and also due to the low participation rate in some studies [14]. Another possible
explanation is the high dropout rate from screening programmes during the programme’s different
implementation stages, as some families prefer to wait and see whether their children improve before
continuing with further evaluations, or because at the time of screening parents state no concern
regarding their child’s development [18]. In any case, the results concerning prevalence from the
different programmes suggest that those that follow a multi-stage strategy, which extends over time,
achieve higher rates, as they cover a wider age range. This conclusion is consistent with the results
available in scientific literature on the age of onset variability and in the different evolutionary trajectory
of the children who come to have autism. Even though studies about the evolutionary trajectories
of early autism symptoms onset are generally based on results obtained from studies with high-risk
populations (i.e., siblings of children with autism) [22–24], these results suggest that symptoms can
manifest in different developmental stages during the first years of life and with different severity
levels. This indicates the need for screening programmes to assume an evolutionary perspective,
combining procedures and instruments that allow detection from very early ages until the end of
early childhood.
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The most commonly used parameters in the appraisal of ASD screening programmes are
sensitivity (Sen) and specificity (Spe), positive predictive value (PPV) and negative predictive value
(NPV). Sen and Spe are intrinsic values to detection tests and have less dependence on prevalence than
PPV and NPV. The values of Sen and Spe measure the diagnostic discrimination of a screening tool in
relation to “gold standard” criteria, which allows the effectiveness of different tools to be compared
and also verify that a screening tool has similar results when applied in different countries, or regions,
if administered in a standardized manner. Almost all selected studies provide Sen and Spe parameters.
The greatest limitation of these parameters is their lack of usefulness in clinical practice, since with this
only information the probability of a person actually having ASD cannot be known. On the other hand,
PPV or NPV measures report the probability of an individual having or not having the disorder based
on whether they have tested positive or negative. The PPV addresses the likelihood that an individual
with a positive result has the disorder. In contrast, NPV indicates the probability that an individual
with a negative result does not actually have ASD. As shown in Table 3, studies using CHAT and
M-CHAT point out that the probability of an individual having ASD, if given a positive test result,
may be between 19% and 60% (PPV between 0.19 in [20] and 0.59 in [14]). Likewise, if the result in one
of these tests is negative, the probability that they do not have ASD is 99%.
The data provided by PPV and NPV are more clinically useful than the values of Sen and Spe;
however, these measures are directly related to the disorder’s prevalence rates obtained in the study.
Thus, if the prevalence of the disorder in the population is low, PPV will be low, despite how sensitive
and specific the screening test is, as is the case in the Spanish study [20]. Therefore, in population
screenings in which the prevalence of the disorder is low, many individuals with a positive test result
happen to be false positives. In contrast, if the prevalence of the disorder is high, the NPV is low,
because detecting fewer people with the disorder will increase the number of false negatives.
As prevalence determines PPV and NPV values, these cannot be used as indexes to compare
two different screening programmes, or to extrapolate results from one study from another. Thus,
it is necessary to use other indexes of evaluation that, besides being useful in clinical practice, do
not depend on the prevalence in the studied population. The parameter proposed by the scientific
literature is that of likelihood ratio (LR). This concept measures the probability of a concrete outcome
(positive or negative) according to the presence or absence of the disorder and depends on the test’s
sensitivity and specificity, hence its usefulness when comparing screening tests. Only two of the
selected programmes in this study provide LR data (see Table 3). Therefore, an effective comparison of
the different programmes in relation to their psychometric properties is not possible.
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Table 3. Psychometrical properties of European ASD Screening studies.
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According to the data collected and the proposed considerations about the psychometric
properties of the screening tools, it can be suggested that almost all studies show reasonable specificity
and sensitivity values; however further follow-up research should be performed to confirm that cases
that are discarded by these procedures are in fact no ASD cases and that ASD positive cases have been
also correctly identified by the different screening programmes.
In the future, progress in screening tools, especially in order to be able to assess their relative
effectiveness and make more befitting decisions about the feasibility of their usefulness in clinical
practice, requires that studies provide psychometric data with values that are independent of the
prevalence rate procured in the studies themselves, using parameters as likelihood ratio. And since
these values are estimated for a specific sample, obtained in a specific place and time interval, it is
recommended for these values to be accompanied by confidence intervals, as in study [18], to facilitate
a better interpretation, taking into account that smaller samples will estimate less accurate values [25].
The follow-up of the detected cases in the screening programmes is an aspect that almost all the
reviewed studies identify as being of great help to confirm doubtful diagnoses at early ages, where
ASD symptomatology can be confused with other developmental disorders. Furthermore, re-screening
at different ages helps in the detection of false negatives (see Table 2). However, it is rare to find
screening studies that report data on children’s communicative and social skills, intelligence quotient
(IQ), or language level at follow-up. Of all the analysed studies only the study conducted in the UK [14]
provides such data, yet, it does not specify whether the evaluated subjects had received any type of
intervention during the time prior to follow-up. This information would be essential for providing
evidence that ASD early detection bolsters intervention at earlier ages and therefore, this may result in
an improvement of the ASD symptomatology.
A poorly researched issue in the described studies is the ethnic, socio-economic and cultural
characteristics of participants, as well as the service accessibility, in the sample population where
the screening programmes were carried out. Each particular case has different possibilities of being
detected in a different screening stage, receiving an ASD diagnosis or not, responding to a treatment
based on factors that are not random, such as services accessibility, the medical-patient relationship,
socio-economic status of the families, their place of residence, etc. [26]. Although many studies do not
offer any data with respect to this, other characteristics have been found among diagnosed ASD cases,
such as that fact that parents (especially mothers) have a high level of education [17,18,21]. In the
Swedish study [19], an interesting fact about the role of immigration was reported, stating that in 50%
of ASD cases both parents were not descendants of people born in Sweden. Information regarding
these issues could help to better understand the risk factors and even the aetiology of ASD. In addition,
it should also be examined if families who have access to better services are somehow influenced by:
(a) whether they reside in more developed and/or thriving communities; (b) whether they have higher
purchasing power; or (c) their educational/cultural level. For this reason, universal screening has a
very important role in reducing healthcare services access inequality. Children with ASD who come
from low-income families, or who live in rural areas, for example, have a significantly higher risk of
receiving a late diagnosis, or even worse, the risk of never receiving a formal diagnosis [27,28]. Thus,
in addition to actions directed at increasing ASD awareness and the proper training of parents and
health professionals, universal screening for ASD can be very useful for reducing social inequality in
the identification and treatment of children with ASD.
3. Strengths and Limitations of European Population-Based ASD Screening Studies
Most of the studies seem to agree on the fact that ASD universal screening helps to identify
children with this disorder at an early age and several studies point out that the majority of false
positive cases are children who have development problems (see Table A1 in Appendix A). Therefore,
autism population screening programmes would also assist in detecting other neurodevelopment
problems and reduce the age of diagnosis in many non-ASD cases as well. The early detection of
neurodevelopmental disorders may result in a faster access to a wider range of resources and services,
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such as early intervention, which could have a significant impact in improving communicative and
social abilities, ultimately reducing symptomatology, a fact that has been demonstrated in several
studies [29–31]. A limitation regarding this matter has been pointed out by the USPSTF working
group [32], which highlights that ASD early intervention studies mainly recruit children from ASD
specialized services and not from universal screening programmes. Therefore, they argue that the
results from these treatment efficacy studies “may not be generalizable” to children identified by
universal screening programmes, which they describe as “younger and possibly less affected children.”
Thus, there is insufficient evidence as there are very few high-quality studies (randomized control trials)
on the efficacy of early intervention programmes with children from universal screening programmes,
which is understandable to a certain extent because it is rather difficult to ethically justify which true
positive case should be included in a waiting list to receive treatment, after the child and his/her
family have already gone through the early detection programme. Regarding the lack of studies with
younger children and children with less severe symptomatology, it may be inferred that children with
less symptomatology should respond better to the intervention. In addition, there is no evidence to
support that children identified through universal screening, rather than based on parents’ concerns,
have a less severe affectation.
However, the lack of studies that provide evidence on early intervention’s effectiveness for
children detected through screening programmes is part of the big question of how to demonstrate
the value of the complex clinical process of ASD detection, diagnosis and intervention, according
to [26]. These authors report that ASD is very difficult to manage within the public health systems,
due to the great variability in the initial manifestations of symptoms (both in terms of initial onset
and intensity of symptoms). In addition, the diversity of developmental patterns can influence the
stability of the diagnosis. This would require more complex interventions and consequently, these
interventions should be adjusted to the individual’s needs in terms of content, application methods
and professionals involved [33]. Nonetheless, it should be noted that all the described studies have
been conducted in collaboration with public health systems, early intervention programmes and
even day-care centres (see Table 2), which indicates that such coordination is possible. Some of
them underline the importance of raising ASD awareness and highlight the relevance of adequate
training in detection programmes, both for professionals involved in their application and for society
in general [19,20]. Furthermore, ASD screening programmes have several stages at different ages and
most of these practices are framed within development surveillance programmes. All these measures
seek to identify the largest possible number of ASD cases within the studied population and to reduce
false negatives cases (see Tables 2 and A3 in Appendix C). There are some screening tools, such as the
M-CHAT, that even have a verification procedure to minimize the number of false positives, which
reduces costs as less diagnostic evaluations are performed.
Another important limitation that must be noted is related to the design of prospective
observational studies in general population cohorts. Data collection is always affected by participation
rates of both professionals who apply the screening tools and the individuals who agree to participate
in the study. Furthermore, studies are also affected by participants’ dropout rates during screening
stages (due to a number of different reasons) as well as sample selection bias. These variables are
very difficult to control, having as a result, estimated prevalence values that should be interpreted
with caution, as well as the psychometric measures of the programme’s effectiveness (see Table A3 in
Appendix C).
4. Early Intervention Treatment Programmes
As discussed throughout this review, it is important to measure the effectiveness of ASD early
detection tools and programmes, in order to estimate the number of diagnosed cases and assess
the available resources destined for early intervention should aim. In light of the need to respond
to the high ASD prevalence with effective treatments, over the last decades scientists have worked
diligently to develop efficient early intervention programmes for young children with autism and even
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though there are a well-known number of approaches to treat ASD, no approach has been identified
to improve the functioning of all treated children with ASD [34]. However, there is a large body of
research dedicated to evaluating the different types of evidence-based early intervention practices
used to treat autism. For instance, the findings of a study conducted by Wong and colleagues [35]
suggest that there are two broad classes of intervention approaches, classifying them in comprehensive
treatment models (CTMs) and focused intervention practices (FIPs). Comprehensive programmes are
a set of practices designed to achieve a wide-ranging learning or developmental impact on the core
deficits of ASD, while focused interventions are designed to address a single skill or goal. Furthermore,
another study on early intervention approaches points out that FIPs usually happen over a moderately
short period of time and such programmes comprise reinforcement, peer-mediated intervention and
prompting. In contrast, CTMs occur over a prolonged period of time, often a year or longer and are
characterized by the intensity of their application [36]. Also, it is important to note that regardless of
their method these early intervention practices for ASD integrate both behavioural and developmental
methods, focusing on the development of social and cognitive skills, such as communication, shared
attention, attention and regulation, imitation and symbolic play [37].
Another important aspect of CTMs is that they typically operate following multidisciplinary
approaches, integrating principles of applied behavioural analysis (ABA) and/or discrete trial training,
developmental and relationship-based procedures, among others; yet in spite of the increased use
of ABA over the last decades, misrepresentations and misunderstandings concerning this approach
continue to be a topic of debate amongst scientists [38]. Although there are differing scientific opinions
with regard to the effectiveness of ABA techniques, in a review of the trends and topics of early
intensive behavioural interventions (EIBIs), a type of CTM that is widely ruled by ABA [39] it has been
proposed that ABA could possibly be the most effective treatment approach for autism. As shown in
Table 4, a summary of the data obtained from a systematic literature review carried out within WP2 in
the framework of the ASDEU project [9], the retrieved studies identified and evaluated the efficacy of
well-established CTMs and provided information regarding intervention outcomes on the core deficits
of autism (see Figure 2 for the study selection process and Table A2 in Appendix B for the electronic
search strategy; more details of the methodology protocol can be provided upon request).
Table 4. Summary of Studies on Early Intervention Comprehensive Treatments.
Study Region Program(s) Approach Setting Intensity Duration
Lidia D’Elia et al.,




a week 24 months





TEACCH Multidisciplinary Publicschools - 1 school year
Isabel M. Smith




home 15 h a week 12 months










clinic 1 h a week 3 months










clinic 2.6 h a week 3 months
Jeff Salt et al., 2002
[45]
United
Kingdom SCA Social Developmental School
8 h, every
2 weeks 10 months
Geraldine Dawson









clinic 20 h a week 24 months
Treatment and Education of Autistic and Related Communication Handicapped Children (TEACCH), Nova Scotia
Early Intensive Behavioural Intervention (NS-EIBI), Parent Delivery of the Early Start Denver Model (P-ESDM),
Scottish Centre for Autism Preschool Treatment Programme (SCA), Early Start Denver Model (ESDM) (-) Information
not reported.
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Figure 2. PRISMA flowchart representing the ide tification nd selection o tudies.
The systematic eva ation f CTMs studie indicate that there is scarce scientific research
evaluating European programmes, as 12 of the 14 studies found in this review were designed and
implemented in America (United States of America and Canada). Als , only two st dies were
conducted in Europe (Italy and United Kingdom), published in scientific English peer-review journals
(to assure the replicability of the study), of which only one evaluated a European programme,
The Scottish Centre for Autism Preschool Treatmen Programme (SCA) [9,45]. Nonetheless, these
findings shed light on the most commonly used treatment programmes, both in Europe and in
other non-European regions. According to the literature, in some European countries programmes
such as Treatment and duc tion of Autistic a Related Communication Handicapped Children
(TEACCH), Early Start Denver Model (ESDM), Parent Delivery of the Early Start Denver Model
(P-ESDM), Early Intensive Behavioural Intervention (EIBI), Early Behavioural Intervention (EBI), Life
skills and Education for Students with Autism and other Pervasive Behavioural Challenges (LEAP)
have been implemented and studied to measure their effectiveness within the European context. It is
important to note that most of the abovementioned programmes, though typically funded by public
grants, are carried out in academic institutions, making it difficult to infer whether they could be
effectively implemented in the public health sector. TEACCH is a comprehensive programme for
children with autism that was established at the University of North Carolina in 1966; its creators
define the treatment method as a collaborative global approach where parents and professionals
work together [47,48]. A standard TEACCH intervention consists of an initial assessment of the
individuals’ abilities through standardized tests, where the results of such an evaluation provide the
foundation for the development of a curriculum that is consistent and suitable for the individual needs
of each child [48]. The programme’s intensity, that is to say, the weekly number of hours of treatment
given, can be classified as low, low-to-medium and medium intensity and the method also includes a
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natural environment (home) intervention. Further, this at-home method may reduce parental stress
levels as well as the parents’ perception of their child’s maladaptive behaviours [40]. This method
has also been studied in school-based settings and the results indicate that children in the TEACCH
programme benefit from this approach, as students made gains across ASD domains and/or reductions
in autism characteristics [41,49,50]. These findings shed some light on the feasibility of implementing
the program in larger, community-based settings; yet, a limitation often noted in most studies is the
impossibility of randomly assigned participants to the intervention programmes.
Another model that has been examined in this review was the Early Intensive Behaviour
Intervention (EIBI), as there are a number of studies that sustain that this intervention, which works
on the principles of applied behaviour analysis (ABA), is effective in treating the core deficits of
ASD [51]. However, when implemented in community-based settings EIBI yields mixed results in
terms of its effectiveness [52]. Nevertheless, empirical research has also shown that when implemented
for a prolonged period of time, EIBI can have robust results on measures of intelligence, expressive
and receptive language, daily living skills and positive behaviour [51]. Similar to other well-known
EIBI models, the Nova Scotia Early Intensive Behaviour Intervention (NS-EIBI) is a programme
that was created for young children with autism to explicitly address the challenge of providing
feasible, sustainable evidence-based intervention that would target the core deficits of autism in
the socialization and communication domains [42]. This intervention combines parent training and
naturalistic one-to-one behaviour intervention using pivotal response treatment techniques and results
from a study aimed at identifying the effectiveness of the programme showed that behavioural
problems decreased significantly over 1-year of treatment and that children also showed improvement
in multiple developmental domains, such as language, communication and adaptive behaviour [42].
However, even though both TEACCH and EIBI are well-known models, amongst the widely
used programmes we can also find the Early-Start Denver Model (ESDM) a comprehensive early
behavioural intervention for toddlers and preschool-aged children developed by psychologists
Sally Rogers, Ph.D. and Geraldine Dawson, Ph.D. The model combines applied behaviour analysis
principles with developmental and relationship-based approaches and was created to address the
needs of young children with ASD as young as 12 months of age; where treatment takes place in a
familiar environment (home) and intervention sessions are delivered by trained professionals and
parents [46]. Empirical studies evaluating the effectiveness of the ESDM and the ESDM Parent Delivery
version indicate that this model is characterized by a rigorous, structured curriculum that is followed
and implemented according to the programme’s guidelines and research findings suggest positive
treatment outcomes as children in these high intensity interventions have shown improvement in
cognitive abilities and domains of socialization, language, daily living skills and motor skills IQ and
adaptive behaviours [43,46,53]. Nonetheless, even though these programmes provide evidence of
positive clinical outcomes on the core deficits of ASD, it does not seem to improve Autism Diagnostic
Observation Schedule (ADOS) scores [46,54]. In regard to this model it is important to note that even
though it widely used in America, there is little information regarding whether it could be successfully
implemented within the European context.
5. European Early Intervention Comprehensive Treatments
Considering the amount of data pertaining to the investigation of CTMs effectiveness in America,
it is somewhat daunting, though perhaps not that surprising, that in European countries there
remains the need to conduct more empirical studies measuring the usefulness and implementation
feasibility of these interventions within the European healthcare system. Nonetheless, in some
European countries, such as Italy and the United Kingdom, studies measuring the efficiency of already
established programmes such as TEACCH, LEAP and EIBI have been conducted [45,55], indicating
that these models have positive intervention outcomes as they are characterized by well-structured
curriculums designed by experienced professionals who take into account each child’s specific
needs, designing and implementing the intervention protocol accordingly. In fact, across studies
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the evaluation of these models pointed out that most commonly used comprehensive programmes
operate on Discrete Trial Training principles, such as Applied Behavioural Analysis (ABA) and
Pivotal Response Treatment (PRT); Picture Exchange Program System (PECS), which supports the
notion that behavioural interventions do seem to provide positive results in ameliorating the clinical
symptomatology of children with ASD, as well as the social and communication impairments that
come with it. Moreover, most studies evaluating ASD treatment effectiveness highlight the importance
of parent involvement, either as at-home therapists or onsite co-therapists who would deliver part
of the intervention and the role it has in both the children’s improvement and in reducing parents’
ASD-related stress levels. Furthermore, these studies also suggest that those programmes where
parents have an active role, either as lead therapists or as co-therapists, seem to have a greater effect
size than those in which there is only a therapist and/or in which the intervention is carried out by
a teacher in a school setting with a therapist’s assistance [9]. Yet, in intervention practices, such as
the TEACCH and LEAP programmes, teacher involvement does seem to play a key role in positive
intervention outcomes, as well as teacher training, which varies across studies (between 10 and 20 h of
training). The implementation of in-class intervention also shows positive results, as well as training
of typically developing children in comprehensive social skills that would facilitate the social and
communicative behaviours of their peers with ASD [40,41].
Although high-intensity comprehensive treatments have been associated with positive
intervention results, procuring studies that investigate the effectiveness of such programmes in
reducing ASD symptoms and improving the core deficits associated with the disorder is more common
than finding scientific work studying low-intensity programs. However, just as comprehensive
treatments have positive intervention results, so do focused intervention practices, as suggested in [56],
which evaluate the social-communicative effects of the Picture Exchange Communication System
(PECS) in treating children with ASD. In this study children were assessed pre- and post-intervention
and the findings indicate that even though there were no significant group differences in standardized
tests scores at baseline (T1), post treatment outcomes (T2) show significant improvement on the VABS
social-domain and social communicative abilities [47]. Moreover, an ongoing study investigating the
efficacy of focused interventions [9] found a positive correlation between the time of treatment and
intervention effectiveness, which supports the notion that the higher the intensity of the intervention
the better outcomes achieved.
Although the replication and implementation of comprehensive and focused programmes in
countries of the European Union has shown positive results [40,57], according to a literature review
conducted under the ASDEU project [9] not many studies have proposed the development and
implementation of a European comprehensive and/or focused programme, except for The Scottish
Centre for Autism Preschool Treatment Programme (SCA). This treatment curriculum, run by a tertiary
service within the Department of Child and Family Psychiatry at Yorkhill Hospital, Scotland, has a
social-developmental approach and follows a well-structured curriculum, as it is supervised by the
programme’s creators, its daily organization is arranged by a programme coordinator and is integrated
by a multidisciplinary team of therapists (nursery nurses, teachers, occupational therapists, speech
and language therapists) all well-trained in the programme’s therapeutic approach [55]. Moreover,
a study conducted to examine the effectiveness of the treatment suggested that having access to
this intervention resulted in positive outcomes for children with ASD, since children receiving the
intervention significantly improved in the measures of social interaction, imitation, daily living skills,
joint attention and adaptive behaviours [45].
Yet, with regard to the subject of ASD early intervention, two aspects must be carefully evaluated:
(1) the profile of the professionals and their training in ASD; and (2) the perspective of family members
regarding the intervention, such as access to treatment, how the intervention is administered, its
duration and post intervention results. In light of the poor data on these two aspects, work package
2 of the ASDEU project [9] launched two surveys within the European union context, one for
families and one for professionals, for better understanding this matter. The data collected from
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these surveys indicates that the geographical location of the intervention centres is one of the most
important elements to be taken into account to reduce treatment delay, as the time it takes to get to
these centres is often one of the main challenges families face when accessing treatment services [9].
Furthermore, another limitation stressed by participants is the facilities where early interventions
take place. Those responding to the surveys also emphasized the importance of better informing
the families about the disorder and also pointed out how relevant it is for professionals working
directly with individuals with ASD to have proper training. Additionally, these findings indicate
the common view that there should be a shared effort to bring ASD awareness and to promote early
intervention coordination, proposing intervention guidelines for different age groups and establish
and well-defined procedure. Lastly, the data collected from [9] emphasizes the importance of providing
evidence-based intervention methods, which is a subject that demands further research.
6. Conclusions
With regard to early detection, the review of screening procedures and experiences in Europe
seems to suggest, as a main concern, the feasibility of standardized and systematic actions to improve
the early identification of children with ASD, reducing the age of diagnosis. Thus, in the programmes
analysed in the present study, detection begins very early, reaching diagnostic ages at an age close
to 24 months. However, in Europe, the age of ASD diagnosis is on average at age 3.5, with great
variability between countries [58], an age which remains to be quite late. The age of diagnosis has
certainly been reduced in the last 25 years but the experiences analysed indicate that it is should
be possible to further reduce this delay [19,20]. The causes of the delay can be very diverse and do
not necessarily have to be associated with a lower development of diagnostic services [59]. Some
sociodemographic characteristics also have an influence, such as the place of residence of the child,
the socioeconomic level of the family, or structural limitations of the services that give rise to long
waits for the child to be diagnosed [28]. The aforementioned causes are variables that intervene in the
temporary space that exists between the parents’ first concerns (if these take place) and the time of
diagnosis. Some key milestones during that period could be the moment when the first concerns of
the parents arise, as well as the first contact with the paediatrician, the assessment of the symptoms
by the paediatrician, the referral to the hospital, the first visit to the hospital and the diagnosis and
subsequent referral to the treatment program. It is probably necessary to deepen the understanding of
the delay in identification and diagnosis but the causes identified so far can be addressed in a simple
manner through specific actions to improve detection adjusted to each country or region, as is the
case of the screening studies reviewed in this article. Efforts to reduce the delay should take into
account the causes that are known and should include, among others, actions aimed at rationalizing
the process from the first concern of the family to the final diagnosis, modify community resources and
state policies through of laws or guidelines of good practice and to promote the education of parents
and professionals on the early recognition of development problems. All this can be done to a large
extent with early detection programs, such as those reviewed here, which are clear examples to follow.
Although it is still necessary to adapt the most convenient actions according to the characteristics and
needs of each country.
Secondly, findings from this review indicate that the screening programmes that yield better
results combine procedures and instruments that allow detection from very early ages until the end
of early childhood. This multi-stage approach in early detection is useful because it improves the
inherent problem pertaining to age of symptoms onset and symptoms’ intensity, as they may vary
from case to case. The strategy of combining different identification procedures during different ages
in a single screening programme deserves to be a research objective, because its practical application
could also serve as a more effective way to reduce the number of false-positive and false-negative cases
within the framework of a development surveillance strategy. However, a development surveillance
strategy without prior proper training in detection tools can invalidate the psychometric properties of
these tools [60]. Therefore, it is necessary that the research and practical application of the screening
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programs include the goal of improving the training of healthcare professionals, increase the support of
private practices and also that health services authorities assume detection as a general responsibility
by promoting the creation of comprehensive networks. Training aimed at professionals should not
only help improve knowledge about the use of specific detection tools but it should also provide
professionals with resources to adequately recognise the signs of concern. This training should be
combined with systematic ASD awareness campaigns aimed at families describing ASD warning signs
and the advantages of early identification. This complementary strategy could be very important
as it could provide a platform to help families express their concerns regarding the disorder with
confidence. Moreover, the findings from the review suggest that the inclusion of a case follow-up
system, not only aimed at detecting false negative cases, would also allow professionals and parents to
identify signs of symptoms improvement due to early intervention. Hence, this strategy could help
both professionals and families to have a more positive perception of autism early detection and also
improve the knowledge on the development of the symptoms of autism and the study of ASD profiles
(cognitive, communicative, etc.).
Thirdly, the reviewed studies show different examples of how to conduct a systematic
identification of children with ASD; however, they are hardly comparable to each other as programmes
do not use the same parameters to appraise screening tools and procedures. Researchers and
professionals who assess detection tools and methods should provide data that report on its
psychometric properties, which would allow to efficiently evaluate the relative effectiveness of each
procedure and to compare different programmes using the same parameters. Thus, studies aimed
at improving detection should provide values of Sen and Spe and VPP and VPN, which may allow
professionals to know the probability of an individual having ASD or not depending on the results
obtained on the tests. Given that the values of VPP and VPN depend on prevalence, it is very useful
that detection studies also provide values of likelihood ratio, a parameter that measures the probability
of a result (positive or negative) according to the presence or absence of the disorder, which does not
depend on prevalence but on the sensitivity and specificity of the test and hence, its usefulness when
comparing screening tests. Providing these psychometric values could be very useful in when making
political and administrative decisions regarding what type of tool or programme could be better to
promote in the European context.
With regard to early intervention programmes, so far there is no specific European model, since
the models found in the scientific literature describe and analyse the results of the application of
programs developed in other regions of the world. However, this seems to indicate that the European
scientific community is following the example of those studies that have shown to be effective.
Furthermore, it can also be inferred that most professionals in Europe take these experiences into
account; although it is still necessary to demonstrate through the publication of scientific reports that
in Europe the early intervention of ASD is comparable to that of the rest of the world. Nonetheless,
the literature devoted to the description and evaluation of early interventions for autism has become
quite vast in recent years. The various treatment models addressed in this review may allow
the formulation of some recommendations that could be taken into account in the field of ASD
early intervention. First, there seems to be an increasing convergence between behavioural and
developmental methods (i.e., ESDM) and research findings suggest that the focus of early interventions
for ASD is directed toward the development of skills considered “pivotal” such as shared attention,
imitation, communication, symbolic play, cognitive abilities, attention and regulation. Second, the
literature proposes some guidelines for effective treatments such as: (1) starting as early as possible;
(2) minimizing the gap between diagnosis and treatment; (3) providing at least 3–4 h of treatment
per day; (4) centring on family involvement; (5) choosing among the behavioural/developmental
approaches depending on the child’s profile and/or treatment response; (6) encouraging spontaneous
communication; (7) promoting skills through play with peers; (8) finalizing the acquisition of new skills,
generalization and maintenance in natural contexts and (9) supporting positive behaviours rather
than just tackling challenging behaviour. Moreover, all studies examining the effectiveness of early
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comprehensive models urge the importance of adequate programme structuring and implementation
by a lead experienced professional (psychologist, specialized interventionist) and a team of well-trained
therapists (psychologists, speech therapists, graduate students, teachers). In this sense, it is likely
that all efforts aimed at improving the training of European professionals could have very favourable
consequences for young children with ASD receiving intervention. It is important to note that most
comprehensive treatment programmes found in the scientific literature that have demonstrated efficacy
follow a behavioural approach, such as Applied Behaviour Analysis (ABA) or Pivotal Response
Training (PRT) and in some instances, these models could also take on a more naturalistic approach
to target core ASD deficits. Moreover, from the review we can infer that when evaluating treatment
effectiveness, studies must comply with certain features such as the presence of a comparable control
group, the presence of precise diagnostic criteria, periodic evaluations during treatment and evaluation
of different developmental aspects (severity of autism, cognitive and language development, global
functioning and quality of family life and parent-child interaction). Furthermore, the presence of
a specialized team in the management and treatment of autism and the active collaboration of the
family in treatment planning and execution could also be considered as two pillars of any treatment
program [61]. Even though for the purpose of this review only early intervention comprehensive
treatment programs were examined, the role of focused practices must also be acknowledged.
Focused interventions, including those programmes aimed at improving parents’ ability to develop
communicative and social skills, also aim to improve the problem behaviours of children with ASD
and reduce the severity of symptoms, such as the program developed by [62,63]. These promising
intervention practices are the subject of analysis within the framework of the study on which this article
is based and the results of this analysis will be presented in an article currently under preparation.
However, several studies suggest [64,65] that conducting studies that will provide empirical evidence
to appraise treatment characteristics, such as timing, intensity, intervention delivery and duration
remains to be a research priority.
There is general agreement in the autism field to find the best detection, diagnostic and
intervention tools and programmes. However, political authorities, parent organizations, professionals
and researchers alike also have a responsibility to support, promote and conduct controlled studies
that can later be transferred from these controlled contexts to clinical practice, within the framework of
protocols protected by public policies that acknowledge the needs of the families of children with ASD
and that provide the public services with the required resources to coordinate and evaluate the efforts
for early ASD identification and intervention, for the sake of young children with ASD.
Finally, it must be highlighted that the search conducted for this review has mainly focused in
European studies and thus, it is important to note and acknowledge that there is a copious amount of
international research on screening and early intervention programme, which could without a doubt be
useful within the European context. However, examining this concept was out of the scope of this study.
Further, more research should be devoted to the investigation and comparison of screening and early
interventions practices from other international backgrounds with the objective of testing feasibility
and exploring other good practices to be applied not only in European contexts but anywhere else.
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Appendix A
Table A1. Electronic search strategy for ASD screening programmes.
1. “developmental disabilities” (Mesh) OR “developmental disabilities” (Title/Abstract) OR “developmental disability” (Title/Abstract) OR “developmental disorders”
(Title/Abstract) OR “developmental disorder” (Title/Abstract) OR “Developmental delay” (Title/Abstract)
2. “autistic disorder” (Mesh Terms) OR (“autistic” (Title/Abstract) AND “disorder” (Title/Abstract)) OR “autistic disorder” (Title/Abstract) OR “autistic disorders”
(Title/Abstract) OR “autism” (Title/Abstract)
3. #1 AND #2
4. “autistic disorder” (MeSH Terms) OR “autistic disorder” (Title/Abstract) OR “autistic disorders” (Title/Abstract) OR “autism” (Title/Abstract) OR “child development
disorders, pervasive” (MeSH Terms) OR “Pervasive developmental disorder” (Title/Abstract) OR “Pervasive developmental disorders” (Title/Abstract) OR “PDD”
(Title/Abstract) OR “autistic spectrum disorder” (Title/Abstract) OR “autistic spectrum disorders” (Title/Abstract) OR “autism spectrum disorder” (Title/Abstract) OR
“autism spectrum disorders” (Title/Abstract) OR “ASD” (Title/Abstract)
5. #3 OR #4
6. “diagnosis” (Mesh:noexp) OR “diagnosis” (Subheading) OR “Detection” (Title/Abstract) OR “diagnosis” (Title/Abstract) OR “Early diagnosis” (Mesh:noexp) OR
“Early diagnosis” (Title/Abstract) OR “Early detection” (Title/Abstract) OR “Early identification” (Title/Abstract) OR “Early intervention” (Title/Abstract) OR “Early
prediction” (Title/Abstract)
7. “screening” (Title/Abstract) OR “Early screening” (Title/Abstract) OR “Mass Screening” (Majr:NoExp) OR “Mass Screening/instrumentation” (Majr:NoExp) OR “Mass
Screening/methods” (Majr:NoExp) OR “mass screening” (Title/Abstract) OR “screening tool” (Title/Abstract) OR “screening tools” (Title/Abstract) OR “screening test”
(Title/Abstract) OR “screening instrument” (Title/Abstract) OR “screening instruments” (Title/Abstract) OR “checklist” (MeSH Terms) OR “Checklist” (Title/Abstract)
OR “Checklists” (Title/Abstract) OR “Follow-up” (Title/Abstract)
8. #6 AND #7
9. #5 AND#8
10. Search range: 1 January 1992–4 January 2015
11. Language: English
12. Academic Journals (Peer Reviewed)
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Appendix B
Table A2. Electronic search strategy for ASD early interventions.
1. Diagnostic: Autism OR ASD OR Autism Spectrum Disorder * OR Autistic Disorder * OR Pervasive Developmental Disorder * OR PDD.
2. Intervention: intervention OR treatment OR therapy OR program OR practice OR strategy OR early intervention OR comprehensive treatment OR comprehensive
model OR integral approach.
3. Model: SCERTS OR SCERTS model OR ABA OR early intensive behavioural intervention OR EIBI OR Denver model OR ESDM OR LEAP OR Program for preschools
and parents.
4. Population: children OR young children OR pre-schooler OR infant OR toddlers.
5. Setting: primary health care OR primary care OR health care system OR preschool OR day-care OR child day-care centres OR primary school OR children centres.
6. #1 AND #2 AND #3 AND #4 AND #5
7. Publication Date: 2000-2016
8. Language: English
9. Source Type: Academic Journals
10. #7 AND #8 AND #9
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Appendix C
Table A3. Strengths and limitations of European ASD screening studies for early detection in general population.
Study Reference Strengths Limitations
Baird at al., 2000 [14]
- The study shows that ASD can be prospectively identified at 18 months of
age, which has important implications for health service resources.
- The CHAT used as a 2-stage procedure has an extremely low false-positive
rate and the PPV for ASD is greater than 50%.
- Early identification of ASD may result in considerable benefit to children
and their families in many ways (e.g., Helping to make informed decisions
about having more children or having earlier intervention).
- Subjects were identified via 5 different methods over the course of 6 years,
leading to higher ascertainment.
- Only 40% of the eligible total population were screened at 18 months
and some children with profound handicap were excluded, hence
the efficiency of the screen in a total population and prevalence
figures are unknown in the study.
- Not all the medium-risk group at CHAT-1 received a second
administration and low risk thresholds were not tested because of
resource constraints.
- As the second administration was performed by the research team, it
is difficult to know how the screen would operate when conducted
by community health practitioners
- No data on the reliability of the instrument.
- High rate of false negatives and low PPV with the full programme.
Dietz et al., 2006 [17]
- First prospective population study to screen for ASD in children aged 14–15
months, showing that early detection is possible.
- None of the false positive cases detected were found to have a
typical development.
- 14-item ESAT test could help clinicians when considering referral for
diagnostic evaluation (screening for children at risk of ASD, Level 2).
- 14-item ESAT test was found to detect ASD in different levels of
cognitive functioning.
- Validity of the screening instrument ESAT was not calculated
because data on the false negative cases was not sufficient.
- The pre-screening test generated a high rate of false positive cases.
- The screening method could fail to detect milder variants of ASD
and/or ASD children with high level of development at 14 months.
- High rate of drop out at this early age, because parents did not want
to cooperate.
- Parents hesitated to cooperate in the study because of delays in the
detection procedure between the home visit and examination at the
Department of Child an Adolescent Psychiatry
Dereu et al., 2010 [18]
- First prospective screening study that incorporates child care workers’
report on signs of ASD in young children.
- CESDD had a better sensitivity than other tests used in random samples.
- Including children with only language delay in further stages of the
screening procedure helped to detect more false negatives.
- Low compliance rate at each stage of the screening procedure due to
different reasons: parents decline invitation, child-care workers did
not want to unnecessarily worry the parents about the development
of their child, or the child was seen at another assessment centre and
the parents did not want to overwhelm their child with
more assessments.
- Screening with the CESDD generated a large number of
false positives.
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Canal-Bedia et al., 2011 [20]
- First official Spanish version of the M-CHAT to be applied in Spain.
- Provides evidence that ASD cases could be detected by the SNHS at around
24 months helping to overcome diagnostic delay in Spain.
- High sensitivity and specificity values.
- Highlights the utility of using specific flowchart forms for each item during
the phone interview.
- Follow-up of false negatives with a monitoring system based on early
intervention units in the education and welfare system.
- The study has identified a clear need for coordination between the health
services and ASD-specific early intervention unit in Spain.
- M-CHAT administration problems such as items being
misunderstood and difficulties in locating families by telephone to
apply the telephone interview.
- Low positive predictive value.
- No follow-up of negatives screen cases to confirm true
negative cases.
- Hard to demonstrate that ASD early-detection program using
M-CHAT within a population-based framework is cost-effective to
be implemented in the SNHS.
Nygren et al., 2012 [19]
- Health care professionals have learnt to use the instruments beyond the
routine screening, increasing awareness and skills for recognition of
symptomatology in ASD.
- The study has notably improved the early diagnosis and intervention for
children with autism by combining the screening methods with new
routines for evaluation. In 2005, only 2 children of less than 3 years were
referred and diagnosed, in 2010 the referred number was 48.
- The screening programme described in the study is currently established as
part of the developmental programme in the Child Health Centres.
- Attritions rates for diverse reasons at different stages of the
programme: parents rejecting further evaluations, moving
abroad, etc.
- Psychometrical properties of the screening programme would not be
possible to estimate with precision until long-term follow-up studies
have been performed.
- The given setting at 2.5-years-old visit would probably have been
optimal half a year earlier.
Stenberg et al., 2014 [21]
- The prospective data collection and the combination of screening, referrals
and registry linkage to identify ASD cases in the study sample, including
children with mild and severe ASD symptoms, has allowed to better deal
with the typical problems from the large population-based cohort design:
rate of participation, losses in follow-up and selection bias.
- Diagnosis reported at a very stable age (3 years).
- Ascertainment of ASD cases in the cohort is not yet completed.
- Incomplete data is likely to have led to an overestimation of the
psychometrical properties.
- Follow-up interviews for positive screen cases in the M-CHAT is
infeasible in a large population-based study like MoBa, with the
consequence of a high rate of false positives.
- The M-CHAT test translation applied was not culturally adapted.
- The study could not assess the impact of social and cultural factors,
such as parental awareness of early developmental markers
associated with ASD and whether timing and composition of
screening instruments can be optimised for maximal public
health impact.
Brain Sci. 2017, 7, 159 24 of 28
Table A3. Cont.
Study Reference Strengths Limitations
Baduel et al., 2017 [10]
- First ASD screening study in a French general population sample, showing
the utility of the M-CHAT in primary-care settings.
- The M-CHAT and the follow-up interview for positives cases in the
questionnaire shows a large decrease in the rate of false positives and
although some false positive cases remain, all cases presented
developmental concerns, suggesting the use of M-CHAT is beneficial not
just for children with ASD.
- Low number of children screened at 24 months due to low
participation of primary care providers.
- High rate of attrition on the follow-ups at 30 (70%) and 36 (35%)
months to assure identification of false negative cases.
- Given the high proportion of children with ASD found in this study,
it is likely that paediatricians did not administer the M-CHAT on a
routine basis to every child who came to their office but used it as a
confirmation test when they had concerns. This underlines the
importance of emphasizing that ASD screening should be systematic
in paediatrician practice.
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53. Eapen, V.; Črnčec, R.; Walter, A. Clinical outcomes of an early intervention program for preschool children
with Autism Spectrum Disorder in a community group setting. Pediatrics 2013, 13. [CrossRef] [PubMed]
54. Vivanti, G.; Dissanayake, C.; Zierhut, C.; Rogers, S.J. Victorian ASELCC Team, Brief Report: Predictors of
Outcomes in the Early Start Denver Model Delivered in a Group Setting. J. Autism Dev. Disord. 2013, 43,
1717–1724. [CrossRef] [PubMed]
55. Salt, J.; Sellars, V.; Shemilt, J.; Boyd, S.; Coulson, T.; McCool, S. The Scottish Centre for Autism preschool
treatment programme. I: A developmental approach to early intervention. Autism 2001, 5, 362–373.
[CrossRef] [PubMed]
56. Lerna, A.; Esposito, D.; Conson, M.; Russo, L.; Massagli, A. Social-communicative effects of the Picture
Exchange Communication System (PECS) in Autism Spectrum Disorder. Int. J. Lang. Commun. Disord. 2012,
47, 609–617. [CrossRef] [PubMed]
Brain Sci. 2017, 7, 159 28 of 28
57. Strauss, K.; Benvenuto, A.; Battan, B.; Siracusano, M.; Terribili, M.; Curatolo, P.; Fava, L. Promoting Shared
Decision Making to strengthen outcome of young children with Autism Spectrum Disorders: The role of
staff competence. Res. Dev. Disabil. 2014, 38, 48–63. [CrossRef] [PubMed]
58. Salomone, E.; Charman, T.; McConachie, H.; Warreyn, P. Child’s verbal ability and gender are associated
with age at diagnosis in a sample of young children with ASD in Europe. Child Care Health Dev. 2016, 42,
141–145. [CrossRef] [PubMed]
59. Mazurek, M.O.; Handen, B.L.; Wodka, E.L.; Nowinski, L.; Butter, E.; Engelhardt, C.R. Age at First Autism
Spectrum Disorder Diagnosis: The Role of Birth Cohort, Demographic Factors, and Clinical Features. J. Dev.
Behav. Pediatr. 2014, 35, 561–569. [CrossRef] [PubMed]
60. Thomas, R.E.; Spragins, W.; Mazloum, G.; Cronkhite, M.; Maru, G. Rates of detection of developmental
problems at the 18-month well-baby visit by family physicians’ using four evidence-based screening tools
compared to usual care: A randomized controlled trial. Child Care Health Dev. 2016, 42, 382–393. [CrossRef]
[PubMed]
61. Narzisi, A.; Colombi, C.; Balottin, U.; Muratori, F. Non-pharmacological treatments in autism spectrum
disorders: An overview on early interventions for pre-schoolers. Curr. Clin. Pharmacol. 2014, 9, 17–26.
[CrossRef] [PubMed]
62. Green, J.; Charman, T.; McConachie, H.; Aldred, C.; Slonims, V.; Howlin, P.; Le Coeteur, A.; Leadbitter, K.;
Hudry, K.; Byford, S.; et al. Parent-mediated communication focused treatment in children with autism
(PACT): A randomized controlled trial. Lancet 2010, 375, 2152–2160. [CrossRef]
63. Green, J.; Wan, M.W.; Guiraud, J.; Holsgrove, S.; McNally, J.; Slonims, V.; Elsabbagh, M.; Charman, T.;
Pickles, A.; Johnson, M.J.; et al. Intervention for infants at risk of developing autism: A case series. J. Autism
Dev. Disord. 2013, 43, 2502–2514. [CrossRef] [PubMed]
64. Webb, S.J.; Jones, E.J.H.; Kelly, J.; Dawson, G. The motivation for very early intervention for infants at high
risk for autism spectrum disorders. Int. J. Speech Lang. Pathol. 2014, 16, 36–42. [CrossRef] [PubMed]
65. Camarata, S. Early identification and early intervention in autism spectrum disorders: Accurate and effective?
Int. J. Speech Lang. Pathol. 2014, 16, 1–10. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
